SCHEMBL20022399

SCHEMBL20022399

CCOC(=O)c1nc(-c2cccnc2)sc1C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 6/20 0.62
DBF4 Q9UBU7 6/20 0.62
KDM4E B2RXH2 5/20 0.53
ALDH1A1 P00352 3/20 0.53
MAPT P10636 2/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
NPC1 O15118 1/20 0.52
POLB P06746 1/20 0.52
NFKB1 P19838 1/20 0.52
RAB9A P51151 1/20 0.52
NFKB2 Q00653 1/20 0.52
RELA Q04206 1/20 0.52
CYP1A2 P05177 2/20 0.51
CYP3A4 P08684 2/20 0.51
LMNA P02545 2/20 0.51
CYP2C19 P33261 1/20 0.51
RARA P10276 1/20 0.50
RARB P10826 1/20 0.50
RARG P13631 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL289684 0.88 CDC7 (0.60) CDC7DBF4KDM4EALDH1A1MAPT
SCHEMBL289392 0.88 CDC7 (0.60) CDC7DBF4KDM4EALDH1A1MAPT
SCHEMBL20026569 0.86 CDC7 (0.59) CDC7DBF4KDM4EALDH1A1MAPT
SCHEMBL18569364 0.85 CDC7 (0.58) CDC7DBF4KDM4EALDH1A1MAPT
SCHEMBL2880217 0.85 RARA (0.66) CDC7DBF4KDM4EALDH1A1MAPT
SCHEMBL22460192 0.84 CDC7 (0.67) CDC7DBF4KDM4EALDH1A1MEN1
SCHEMBL13437313 0.83 CDC7 (0.56) CDC7DBF4KDM4EALDH1A1MAPT
SCHEMBL6505435 0.82 CYP3A4 (0.57) CDC7DBF4KDM4EALDH1A1MAPT
SCHEMBL13602416 0.82 KDM4E (0.58) CDC7DBF4KDM4EALDH1A1MAPT
SCHEMBL2881465 0.82 CDC7 (0.72) CDC7DBF4KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180093968-A1 QUINOLINE DERIVATIVES AS TAM RTK INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093968-A1 QUINOLINE DERIVATIVES AS TAM RTK INHIBITORS TYRO3, MERTK, AXL CDC7 693/4885DBF4 3001/4885KDM4E 1123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.